Baptist Health System completes final steps to become the first in South Central Texas to implement an eICU?® program designed to improve critical care delivery and save lives. "eGuardian" utilizes the eICU?® Program from Philips VISICU, that combines early warning software and remote monitoring to connect off-site critical care physicians and nurses to ICU patients around the clock.

Apnex Medical announced today that preliminary data from a first-in-man clinical study showed significant improvements in sleep for people suffering from obstructive sleep apnea. The Apnex HGNS?„? System, developed by the St. Paul-based company, is a device designed to treat OSA, which is a serious life-threatening illness characterized by fragmented sleep and excessive day-time sleepiness.

Athersys, Inc. today presented data supporting its MultiStem?® programs in cardiovascular disease, neurological disease and immune system modulation, and highlighted advancements in other areas, including progress in its drug development program in the area of obesity.

The National Association of Nurse Practitioners in Women's Health announced the launch of Estrogen Therapy I.Q. a campaign devoted to improving access to credible information about menopause and advances in estrogen therapy.

The hormone leptin, typically associated with body weight regulation, works within the central nervous system (CNS) to aid the immune system's defense against sepsis, researchers say.